The purpose of the assessment is to address the research question whether the use of the technologies in question is more effective and/or safer than their comparators, which were chosen based on CE mark indications, recommendations in clinical guidelines for the treatment of MR and EUnetHTA guidelines.
Final version of the assessment was published in September 2015
Below is the documentation provided by the Joint Assessment authoring team:
WP5-SB-15_Comments Tables
WP5-SB-15_Final Project Plan
Transcatheter Implantable Devices for mitral valve repair in adults with chronic mitral valve regurgitation_Rapid REA_Final_Sep 2015_0
